272
Participants
Start Date
July 16, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
August 31, 2026
Standard of Care
Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
Revita
Participants will receive weekly applications of Revita and Standard of Care until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
Relese
Participants will receive weekly applications of Relese and Standard of Care until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
Cogenex
Participants will receive weekly applications of Cogenex and Standard of Care until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
Enverse
Participants will receive weekly applications of Enverse and Standard of Care until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
NOT_YET_RECRUITING
SerenaGroup Research South, Jefferson Hills
RECRUITING
SerenaGroup Monroeville, Monroeville
NOT_YET_RECRUITING
Armstrong County Memorial Hospital, Kittanning
RECRUITING
SerenaGroup Omaha Research Center, Omaha
RECRUITING
Wound Care of Tulsa, Tulsa
SerenaGroup, Inc.
NETWORK
StimLabs
INDUSTRY